Background CMV-D+/R− serostatus is the only well-established risk factor for late-onset
cytomegalovirus (CMV) infection/disease (ie, incident CMV infection/disease after cessation …

AA Boudreault, H. Xie, RM Rakita, JD Scott, CL Davis, M. Boeckh, AP Limaye. Risk factors
for late‐onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney …

Background. During the contemporary era of antiviral prophylaxis, the impact of delayed-
onset primary cytomegalovirus (CMV) disease on the outcome of kidney transplantation is …

Background Use of prophylactic anti-CMV therapy for 3 to 6 months after kidney
transplantation can result in delayed-onset CMV disease. We hypothesized that delayed …

There is notable heterogeneity in the implementation of cytomegalovirus (CMV) prevention
practices among CMV‐seropositive (R+) kidney transplant (KT) recipients. In this …

PURPOSE: Risk factors, sites, and mortality of hospitalized cytomegalovirus (CMV) disease
in renal transplant recipients have not been studied in a national population. METHODS …

Background: Despite a reduction in the incidence of cytomegalovirus (CMV) infections after
kidney transplantation, less is known about late CMV infection in kidney transplant …

Purpose Evaluate cytomegalovirus (CMV) post‐prophylaxis surveillance in high‐risk (D+/R‐
) kidney and liver transplant recipients. Methods Adult D+/R‐patients were included if …

Impact of early cytomegalovirus infection and disease on long-term recipient and kidney
graft survival. Background The impact of cytomegalovirus (CMV) infection and disease on …

Background. Cytomegalovirus (CMV) D+/R− solid-organ transplant (SOT) recipients carry
increased risk of developing CMV disease; however, other risk factors in these patients have …